West Michigan Advisors’s CorMedix CRMD Stock Holding History

West Michigan Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$518K	Hold	66,000	–	–	0.1%	177
2026 Q1	$448K	Hold	66,000	–	–	0.1%	185
2025 Q4	$768K	Buy	66,000 +33,000	+100%	+$365K	0.18%	127
2025 Q3	$384K	Buy	+33,000	New	+$399K	0.09%	180

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

West Michigan Advisors's CRMD Position: Q2 2026 in Review

West Michigan Advisors held its CorMedix (CRMD) position steady in Q2 2026 at 66,000 shares worth $518K. The position accounts for 0.1% of the portfolio, ranked #177.

West Michigan Advisors first reported a position in CRMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $768K in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

West Michigan Advisors held 66,000 shares of CorMedix worth $518K as of Q2 2026.
West Michigan Advisors left its CorMedix share count unchanged in Q2 2026.
CorMedix made up 0.1% of West Michigan Advisors's portfolio in Q2 2026, its #177 holding.
West Michigan Advisors first reported a position in CorMedix in Q3 2025 and has held it in 4 quarters since.
West Michigan Advisors's CorMedix position peaked at $768K in Q4 2025.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on West Michigan Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.